Contact Us | Press Office | International | Academy | About Us | Donate
Share this article
4th Oct 2019
Do you have a baby aged 7 months or younger? Then they could part in a new research trial into respiratory syncytial virus (RSV).
Respiratory syncytial virus (RSV) is estimated to be responsible for more than 16,000 hospital admissions in infants every year. Alder Hey’s Clinical Research Facility are recruiting to a trial, aiming to develop a new vaccine to prevent RSV lung infection in infants.
RSV lung infection is a major cause of cough, colds and chest infections in infants. The younger the child, the higher the risk.
If your child is under 6-7 months of age and you are interested in taking part, please contact us for an informal chat and to find out more:
Please contact us on (0151) 252 5115/5744
The principal investigator at the site is - Dr David Porter, Paediatric Infectious Diseases Consultant.
Keep up to date on all of the latest research trial news on Twitter, follow the team @CRFAlderHey
Our Clinical Research team look forward to hearing from you!
Alder Hey Children's Charity